These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 769952)
21. [Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy (author's transl)]. Fülle HH Med Klin; 1977 Apr; 72(15):642-9. PubMed ID: 266111 [TBL] [Abstract][Full Text] [Related]
22. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499 [TBL] [Abstract][Full Text] [Related]
24. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine. Poth JL; Johnson PK; George RP; Schrier SL Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367 [TBL] [Abstract][Full Text] [Related]
25. Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanine. Mandelli F; Amadori S; De Luca AM; Deriu L; De Rossi G; Isacchi G; Mariani G; Monarca B; Papa G; Di Giovanni F Haematologica; 1977 Apr; 62(2):167-84. PubMed ID: 406174 [No Abstract] [Full Text] [Related]
26. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone]. Marín P; Grañena A; Carreras E; Ribera JM; Rozman C Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237 [No Abstract] [Full Text] [Related]
27. Therapy in childhood acute nonlymphocytic leukemia (ANLL). Evolution of current concepts of chemotherapy. Steuber CP Am J Pediatr Hematol Oncol; 1981; 3(4):379-88. PubMed ID: 6174052 [TBL] [Abstract][Full Text] [Related]
28. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982]. Kurrle E; Hoelzer D; Heimpel H Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646 [TBL] [Abstract][Full Text] [Related]
29. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Yates JW; Wallace HJ; Ellison RR; Holland JF Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956 [No Abstract] [Full Text] [Related]
30. [Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)]. Büchner Th; Kamanabroo D; Urbanitz D; Hiddemann W; van de Loo J Blut; 1978 Jun; 36(6):372-6. PubMed ID: 274968 [TBL] [Abstract][Full Text] [Related]
31. Acute granulocytic leukemia in adults. Frei E N Engl J Med; 1972 Jun; 286(22):1211-2. PubMed ID: 4502491 [No Abstract] [Full Text] [Related]
32. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. Lönnqvist B; Andersson B; Björkholm M; Engstedt L; Gahrton G; Hast R; Holm G; Killander A; Lantz B; Lockner D; Mellstedt H; Palmblad J; Paul C; Peterson C; Simonsson B; Stalfelt AM; Udén AM; Wadman B; Oberg G Cancer Chemother Pharmacol; 1982; 9(2):89-92. PubMed ID: 7172410 [TBL] [Abstract][Full Text] [Related]
33. [Advances in the treatment of acute leukemia in adults]. Pawelski S Acta Haematol Pol; 1973; 4(4):283-9. PubMed ID: 4772918 [No Abstract] [Full Text] [Related]
34. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group. Scand J Haematol; 1979 Aug; 23(2):119-23. PubMed ID: 386480 [No Abstract] [Full Text] [Related]
35. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report. Paolino W; Resegotti L; Rossi M; Infelise V Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626 [TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia. Lewis JP; Linman JW; Marshall GJ; Pajak TF; Bateman JR Cancer; 1977 Apr; 39(4):1387-96. PubMed ID: 322835 [TBL] [Abstract][Full Text] [Related]
37. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study. Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749 [TBL] [Abstract][Full Text] [Related]
38. [General remarks on the treatment of acute leukemias]. Bernard J Minerva Med; 1975 Jul; 66(52):2625-8. PubMed ID: 1057057 [No Abstract] [Full Text] [Related]
39. [Preliminary results of cytosine arabinoside therapy in various chemotherapeutic combinations in acute leukemias]. Fontana G; Rizzo SC; Barosi G Haematologica; 1972; 57(7):389-96. PubMed ID: 4628585 [No Abstract] [Full Text] [Related]
40. Maintenance therapy of adult acute nonlymphoblastic leukemia: an argument against the need for central nervous system prophlyaxis. Armitage JO; Burns CP Cancer; 1978 Feb; 41(2):697-700. PubMed ID: 272947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]